We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$14.8B
AUM Growth
+$2.92B
(+25%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$217M |
| 2 |
Apple
AAPL
|
+$208M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Amazon
AMZN
|
+$136M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Gilead Sciences
GILD
|
+$107M |
| 3 |
PR
Permian Resources
PR
|
+$85.4M |
| 4 |
Reddit
RDDT
|
+$84.1M |
| 5 |
Keysight
KEYS
|
+$79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Technology | 25.64% |
| 3 | Financials | 7.58% |
| 4 | Industrials | 6.88% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACLX
351
DELISTED
Arcellx
ACLX
| $9.64M | 0.07% |
125,649
+14,660
| +13% | +$1.27M |
|
352
Palantir
PLTR
$375B
| $9.63M | 0.07% |
+127,379
| New | +$7.42M |
|
353
Jazz Pharmaceuticals
JAZZ
$16.7B
| $9.55M | 0.06% |
77,564
-201,644
| -72% | -$23.8M |
|
|
SPR
354
DELISTED
Spirit AeroSystems
SPR
| $9.53M | 0.06% |
279,677
-193,867
| -41% | -$6.26M |
|
355
Fabrinet
FN
$19.5B
| $9.53M | 0.06% |
43,329
+32,465
| +299% | +$7.83M |
|
356
S&P Global
SPGI
$119B
| $9.5M | 0.06% |
+19,075
| New | +$9.68M |
|
|
SARO
357
StandardAero Inc
SARO
$9.97B
| $9.45M | 0.06% |
+381,856
| New | +$11.1M |
|
358
ProQR Therapeutics
PRQR
$268M
| $9.43M | 0.06% |
+3,557,001
| New | +$11.3M |
|
359
Morgan Stanley
MS
$336B
| $9.37M | 0.06% |
+74,497
| New | +$9.17M |
|
360
MeiraGTx Holdings
MGTX
$1.18B
| $9.35M | 0.06% |
+1,535,124
| New | +$9M |
|
361
Allogene Therapeutics
ALLO
$680M
| $9.29M | 0.06% |
4,360,232
-4,068
| -0.1% | -$10K |
|
362
Vertiv
VRT
$106B
| $9.27M | 0.06% |
81,552
-327,191
| -80% | -$38.8M |
|
363
Simon Property Group
SPG
$71.9B
| $9.22M | 0.06% |
53,543
-19,851
| -27% | -$3.48M |
|
|
CNTA
364
DELISTED
Centessa Pharmaceuticals
CNTA
| $9.14M | 0.06% |
545,645
+29,266
| +6% | +$485K |
|
365
JB Hunt Transport Services
JBHT
$25.1B
| $9.1M | 0.06% |
53,337
-88,426
| -62% | -$15.8M |
|
366
Kanzhun
BZ
$7.19B
| $9.1M | 0.06% |
+659,251
| New | +$9.7M |
|
367
Kimco Realty
KIM
$16.4B
| $9.06M | 0.06% |
+386,552
| New | +$9.36M |
|
368
Structure Therapeutics
GPCR
$3.74B
| $9.06M | 0.06% |
333,901
+2,328
| +0.7% | +$82.6K |
|
369
ServiceNow
NOW
$121B
| $9.02M | 0.06% |
42,555
-28,015
| -40% | -$5.68M |
|
370
GE Aerospace
GE
$389B
| $8.99M | 0.06% |
+53,901
| New | +$9.62M |
|
371
Agilent Technologies
A
$39.9B
| $8.97M | 0.06% |
+66,797
| New | +$9.15M |
|
372
Blackrock
BLK
$175B
| $8.96M | 0.06% |
+8,743
| New | +$8.87M |
|
373
Texas Instruments
TXN
$254B
| $8.92M | 0.06% |
+47,574
| New | +$9.51M |
|
374
NextEra Energy
NEE
$176B
| $8.85M | 0.06% |
+123,496
| New | +$9.59M |
|
375
Hershey
HSY
$36.8B
| $8.82M | 0.06% |
+52,070
| New | +$9.34M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.
- Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
- Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
- Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
- Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
- Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
- Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
- Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.
Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.